Serge Belanger
Stock Analyst at Needham
(4.48)
# 276
Out of 5,050 analysts
387
Total ratings
54.72%
Success rate
19.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $36 → $34 | $24.03 | +41.49% | 8 | Nov 7, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $40 → $46 | $36.76 | +25.14% | 10 | Nov 5, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $20 → $18 | $7.09 | +153.88% | 18 | Nov 4, 2025 | |
| LQDA Liquidia | Maintains: Buy | $36 → $52 | $26.09 | +99.31% | 34 | Nov 4, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Buy | $55 | $38.25 | +43.79% | 13 | Nov 4, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $22 → $30 | $24.23 | +23.81% | 23 | Oct 28, 2025 | |
| COLL Collegium Pharmaceutical | Reiterates: Buy | $46 | $42.30 | +8.75% | 26 | Oct 28, 2025 | |
| OMER Omeros | Reiterates: Hold | n/a | $6.59 | - | 9 | Oct 15, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $15 → $20 | $10.85 | +84.33% | 5 | Oct 1, 2025 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $66 → $20 | $10.63 | +88.15% | 14 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $10.78 | +159.74% | 21 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $60.16 | +19.68% | 24 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $19.23 | +87.21% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.10 | +172.73% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $11.01 | +99.82% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $27.44 | +23.91% | 18 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $22 | $6.56 | +235.37% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 | $3.72 | +1,109.68% | 16 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $10.76 | +85.87% | 18 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $3.46 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $22.04 | +36.12% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $2.66 | +50.38% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.04 | - | 1 | Mar 31, 2022 |
Amphastar Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $24.03
Upside: +41.49%
NewAmsterdam Pharma Company
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $36.76
Upside: +25.14%
BioCryst Pharmaceuticals
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $7.09
Upside: +153.88%
Liquidia
Nov 4, 2025
Maintains: Buy
Price Target: $36 → $52
Current: $26.09
Upside: +99.31%
Xenon Pharmaceuticals
Nov 4, 2025
Reiterates: Buy
Price Target: $55
Current: $38.25
Upside: +43.79%
Arcutis Biotherapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $22 → $30
Current: $24.23
Upside: +23.81%
Collegium Pharmaceutical
Oct 28, 2025
Reiterates: Buy
Price Target: $46
Current: $42.30
Upside: +8.75%
Omeros
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.59
Upside: -
Ocular Therapeutix
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $10.85
Upside: +84.33%
MoonLake Immunotherapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $66 → $20
Current: $10.63
Upside: +88.15%
Sep 12, 2025
Reiterates: Buy
Price Target: $28
Current: $10.78
Upside: +159.74%
Sep 2, 2025
Reiterates: Buy
Price Target: $72
Current: $60.16
Upside: +19.68%
Aug 27, 2025
Initiates: Buy
Price Target: $36
Current: $19.23
Upside: +87.21%
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.10
Upside: +172.73%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $11.01
Upside: +99.82%
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $27.44
Upside: +23.91%
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $6.56
Upside: +235.37%
Jul 17, 2025
Downgrades: Hold
Price Target: $45
Current: $3.72
Upside: +1,109.68%
Jun 24, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $10.76
Upside: +85.87%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.46
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $22.04
Upside: +36.12%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $2.66
Upside: +50.38%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.04
Upside: -